- Home
- KFY vs SRRK Comparison
KFY vs SRRK Comparison
Compare KFY & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFY
- SRRK
- Stock Information
- Founded
- KFY 1969
- SRRK 2012
- Country
- KFY United States
- SRRK United States
- Employees
- KFY N/A
- SRRK N/A
- Industry
- KFY Diversified Commercial Services
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KFY Consumer Discretionary
- SRRK Health Care
- Exchange
- KFY Nasdaq
- SRRK Nasdaq
- Market Cap
- KFY 3.6B
- SRRK 3.0B
- IPO Year
- KFY 1999
- SRRK 2018
- Fundamental
- Price
- KFY $69.08
- SRRK $27.93
- Analyst Decision
- KFY Buy
- SRRK Strong Buy
- Analyst Count
- KFY 2
- SRRK 10
- Target Price
- KFY $80.00
- SRRK $46.11
- AVG Volume (30 Days)
- KFY 414.3K
- SRRK 3.8M
- Earning Date
- KFY 12-04-2025
- SRRK 11-11-2025
- Dividend Yield
- KFY 2.81%
- SRRK N/A
- EPS Growth
- KFY 33.45
- SRRK N/A
- EPS
- KFY 4.69
- SRRK N/A
- Revenue
- KFY $2,763,755,000.00
- SRRK N/A
- Revenue This Year
- KFY $4.39
- SRRK N/A
- Revenue Next Year
- KFY $4.42
- SRRK $1,849.81
- P/E Ratio
- KFY $14.59
- SRRK N/A
- Revenue Growth
- KFY 0.93
- SRRK N/A
- 52 Week Low
- KFY $59.23
- SRRK $22.71
- 52 Week High
- KFY $80.64
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- KFY 42.57
- SRRK 34.63
- Support Level
- KFY $67.93
- SRRK $29.00
- Resistance Level
- KFY $70.34
- SRRK $43.48
- Average True Range (ATR)
- KFY 1.45
- SRRK 2.87
- MACD
- KFY -0.06
- SRRK -1.26
- Stochastic Oscillator
- KFY 22.49
- SRRK 2.02
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.